Primary |
Hypertension |
26.3% |
Product Used For Unknown Indication |
26.3% |
Anxiety |
10.5% |
Atrial Fibrillation |
10.5% |
Blood Pressure |
5.3% |
Heart Rate Irregular |
5.3% |
Palpitations |
5.3% |
Supraventricular Extrasystoles |
5.3% |
Ventricular Tachycardia |
5.3% |
|
Pharmaceutical Product Complaint |
10.0% |
Product Substitution Issue |
10.0% |
Renal Failure |
10.0% |
Shock |
10.0% |
Bradycardia |
5.0% |
Drug Dispensing Error |
5.0% |
Drug Ineffective |
5.0% |
Drug Toxicity |
5.0% |
Inadequate Analgesia |
5.0% |
Multi-organ Failure |
5.0% |
No Adverse Event |
5.0% |
Pain In Extremity |
5.0% |
Product Quality Issue |
5.0% |
Therapeutic Agent Toxicity |
5.0% |
Toxicity To Various Agents |
5.0% |
Vomiting |
5.0% |
|
Secondary |
Drug Use For Unknown Indication |
29.2% |
Hypertension |
14.0% |
Ischaemic Cardiomyopathy |
8.1% |
Thrombosis Prophylaxis |
7.1% |
Foetal Exposure During Pregnancy |
6.2% |
Anxiety |
4.5% |
Product Used For Unknown Indication |
3.9% |
Hypothyroidism |
3.6% |
Vitamin D Deficiency |
3.6% |
Atrial Fibrillation |
2.6% |
Infarction |
2.6% |
Renal Transplant |
2.6% |
Cardiac Failure |
1.9% |
Type 2 Diabetes Mellitus |
1.9% |
Diabetes Mellitus Non-insulin-dependent |
1.6% |
Myocardial Infarction |
1.6% |
Coronary Artery Disease |
1.3% |
Diabetes Mellitus |
1.3% |
Pain |
1.3% |
Hypercholesterolaemia |
1.0% |
|
Toxic Skin Eruption |
16.7% |
Renal Failure |
9.3% |
Sepsis |
9.3% |
Vomiting |
9.3% |
Orthostatic Hypotension |
7.4% |
Malaise |
5.6% |
Renal Failure Acute |
5.6% |
Tachypnoea |
5.6% |
Tendon Rupture |
5.6% |
Hypoglycaemia |
3.7% |
Lupus-like Syndrome |
3.7% |
Urine Arsenic Increased |
3.7% |
Angioedema |
1.9% |
Brain Death |
1.9% |
Chest Discomfort |
1.9% |
Congenital Renal Cyst |
1.9% |
Drug Toxicity |
1.9% |
Ear Malformation |
1.9% |
Fall |
1.9% |
Folliculitis |
1.9% |
|
Concomitant |
Drug Use For Unknown Indication |
22.6% |
Product Used For Unknown Indication |
20.4% |
Hypertension |
14.5% |
Urinary Tract Infection |
6.9% |
Rheumatoid Arthritis |
5.7% |
Prophylaxis |
4.3% |
Pain |
3.4% |
Pulmonary Embolism |
2.5% |
Osteoporosis |
2.5% |
Atrial Fibrillation |
2.3% |
Cardiac Disorder |
2.1% |
Diabetes Mellitus |
2.0% |
Type 2 Diabetes Mellitus |
2.0% |
Depression |
1.6% |
Multiple Myeloma |
1.3% |
Non-small Cell Lung Cancer |
1.3% |
Hypercholesterolaemia |
1.2% |
Thrombosis Prophylaxis |
1.2% |
Gastrooesophageal Reflux Disease |
1.2% |
Coronary Artery Disease |
1.1% |
|
White Blood Cell Count Increased |
16.0% |
Renal Failure Acute |
9.1% |
Vomiting |
8.7% |
Myocardial Infarction |
6.8% |
Renal Failure |
6.8% |
Weight Decreased |
5.9% |
Nausea |
5.0% |
Death |
4.1% |
Hyponatraemia |
3.7% |
Pyrexia |
3.7% |
Thrombocytopenia |
3.7% |
Transient Ischaemic Attack |
3.7% |
Pain In Extremity |
3.2% |
Sepsis |
3.2% |
Transaminases Increased |
3.2% |
Neuropathy Peripheral |
2.7% |
Pancreatitis Acute |
2.7% |
Skin Plaque |
2.7% |
Wrist Fracture |
2.7% |
Condition Aggravated |
2.3% |
|
Interacting |
Drug Use For Unknown Indication |
81.8% |
Pulmonary Embolism |
9.1% |
Type 2 Diabetes Mellitus |
9.1% |
|
Hypoglycaemia |
50.0% |
White Blood Cell Count Increased |
50.0% |
|